Onto Innovation financials
$304.69+5.52%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Jan 3 | FY24 Dec 28 | FY23 Dec 30 | FY22 Dec 31 | FY21 Jan 1 | FY20 Dec 26 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.01B | $987.3M | $815.9M | $1.01B | $788.9M | $556.5M | $305.9M |
| Gross profit | $499.8M | $515.3M | $420.3M | $539.2M | $429.1M | $278.5M | $135.0M |
| Gross margin | 49.7% | 52.2% | 51.5% | 53.6% | 54.4% | 50.0% | 44.1% |
| Operating income | $132.9M | $187.1M | $116.1M | $236.7M | $156.4M | $26.7M | -$5.0M |
| Net income | $136.8M | $201.7M | $121.2M | $223.3M | $142.3M | $31.0M | $1.9M |
| Net margin | 13.6% | 20.4% | 14.9% | 22.2% | 18.0% | 5.6% | 0.6% |
| Diluted EPS | $2.78 | $4.06 | $2.46 | $4.49 | $2.86 | $0.63 | $0.06 |
| EBITDA | $211.8M | $258.4M | $186.9M | $301.4M | $222.2M | $94.3M | $11.4M |
| Operating cash flow | $328.3M | $245.7M | $172.0M | $136.7M | $175.3M | $106.0M | $18.1M |
| Free cash flow | $299.8M | $213.8M | $149.4M | $118.3M | $163.2M | $102.2M | $11.3M |
| Diluted shares | 49.3M | 49.7M | 49.3M | 49.8M | 49.7M | 49.5M | 30.0M |
Balance sheet
| Period end | Jan 3 | Dec 28 | Dec 30 | Dec 31 | Jan 1 | Dec 26 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $346.1M | $212.9M | $233.5M | $175.9M | $169.6M | $136.7M |
| Short-term investments | $293.5M | $639.4M | $464.3M | $371.9M | $341.7M | $237.0M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $2.37B | $2.12B | $1.91B | $1.79B | $1.65B | $1.47B |
| Total liabilities | $267.1M | $191.2M | $173.2M | $198.4M | $223.8M | $203.4M |
| Shareholders' equity | $2.10B | $1.93B | $1.74B | $1.60B | $1.43B | $1.26B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology